Hepatitis Vaccine

Hepatitis Vaccines Current Updates

The best way to prevent hepatitis A is through vaccination with the hepatitis A vaccine. Vaccination is recommended for all children age 12 months and older, for travelers to certain countries, and for people at high risk for infection with the virus.

The hepatitis A vaccine is given as two shots, six months apart. The hepatitis A vaccine also comes in a combination form, containing both hepatitis A and B vaccine, that can be given to persons 18 years of age and older. This form is given as three shots, over a period of six months or as three shots over one month and a booster shot at 12 months.

For Children: The first dose should be given at 12-23 months of age. Children who are not vaccinated by two years of age can be vaccinated at later visits.

For Travelers: Hepatitis A vaccine is recommended for healthy international travelers age 12 months or older; the first dose of Hepatitis A vaccine should be administered as soon as travel is considered. A shot called immune globulin (IG) can be considered in addition to hepatitis A vaccine for older adults, immunocompromised persons, and persons with chronic liver disease or other chronic medical conditions who are traveling within two weeks. IG without hepatitis A vaccine can be given to travelers who are younger than 12 months of age, allergic to a vaccine component, or who elect not to receive vaccine.

For Others: The hepatitis A vaccine series may be started whenever a person is at risk of infection:

• Men who have sexual contact with other men
• Users of certain illegal drugs, both injection and non-injection
• Family and caregivers before arrival of international adoptees
• People with chronic (lifelong) liver diseases.
• People who are treated with clotting-factor concentrates
• People who work with hepatitis A infected animals or in a hepatitis A research laboratory

Hepatitis vaccines 2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. With the generous response and support received from the participants of previous vaccines conferences. OMICS Internationalproudly announces “International Conference on Hepatitis Vaccines” which will be held during June 16–18, 2016 in Rome, Italy. The Theme of the conference is “Innovative research’s & technologies in Hepatitis Vaccines”.

List of Best International Conferences:

• International Conference on Hepatitis Vaccines, July 25-26, 2016, Australia
• 3rd World Congress on Hepatitis and Liver Diseases, Oct 17-19, 2016, UAE
• 2nd International Conference on Hepatology, May 12-14, 2016, USA
• Annual Conference on Virulent HIV Vaccines, July 28-30, 2016, Thailand
• 4th International Conference on HIV/AIDS, STDs, & STIs, Oct 3-5, 2016, USA
• International HBV Meeting, Germany
• HepDart 2015, Hawaii
• The Liver Meeting 2015, USA
• 2nd Hepatitis Cure & Eradication Meeting 2015, Canada
• 4th Canadian Symposium on Hepatitis C Virus, Canada